
GC75037
GSK360A
Also known as 2-[[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxoquinoline-3-carbonyl]amino]acetic acid
GSK360A is a potent and orally active HIF-PHD inhibitor with IC50 values of 10, 100, and 126 nM for PHD1, PHD2, and PHD3, respectively
ChemicalCAS931399-19-8MW348.33FormulaC17H17FN2O5
- CAS number
- 931399-19-8
- Molecular weight
- 348.33
- Formula
- C17H17FN2O5
- Solubility
- DMSO: 2 mg/mL (5·74 mM; Need ultrasonic and warming)
- InChIKey
- TYHRZQVUPPODPT-UHFFFAOYSA-N
- Catalogue number
- GC75037
- Brand
- GLPBIO
Computed properties PubChem CID 54685147 · XLogP 2.6 · TPSA 107 Ų · H-bond donors 3
- XLogP
- 2.6
- TPSA
- 107 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 25
SMILES C1CC1CCN2C3=C(C=C(C=C3)F)C(=C(C2=O)C(=O)NCC(=O)O)O
Computed descriptors from PubChem (CID 54685147), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il